LCN2 and Insulin resistance: Thus, because LCN2 acts as an anorexigenic signal, the next step was to examine whether LCN2 elevation in obese mice and humans might be a compensatory mechanism to combat obesity, insulin resistance, and other metabolic dysregulations.